51662-1602-1 : NDC 2026 Code

51662-1602-1 : Labetalol Hcl ( Labetalol Hcl )

Additionally :

You can get information about “51662-1602-1” NDC code in 51662-1602-1 in HTML format

HTML | 51662-1602-1 in TXT (Plain Text) format

TXT | 51662-1602-1 in PDF (Portable Document Format)

PDF | 51662-1602-1 in XML format

XML formats.

NDC Code : 51662-1602-1 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "51662-1602-1",
    "PackageDescription": "1 VIAL in 1 BOX, UNIT-DOSE (51662-1602-1)  &gt; 20 mL in 1 VIAL",
    "NDC11Code": "51662-1602-01",
    "ProductNDC": "51662-1602",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Labetalol Hcl",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Labetalol Hcl",
    "DosageFormName": "INJECTION",
    "RouteName": "INTRAVENOUS",
    "StartMarketingDate": "20220829",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA075303",
    "LabelerName": "HF Acquisition Co LLC, DBA HealthFirst",
    "SubstanceName": "LABETALOL HYDROCHLORIDE",
    "StrengthNumber": "5",
    "StrengthUnit": "mg/mL",
    "Pharm_Classes": "Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2022-10-04",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20220829",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}